Cafepharma Today

June 10 2025 - Novo Nordisk starts new CagriSema weightloss drug trial
Novo Nordisk starts new CagriSema weightloss drug trial
Vaccine stocks muted as Wall Street takes 'wait and watch' approach after Kennedy's shake-up
A medical device trade war is brewing between the EU and China
Merck antibody drug for RSV approved by FDA
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Johnson & Johnson And Medivation: A Prostate Cancer Marketshare
Seeking Alpha
Tuesday, January 7, 2014 - 12:51pm
tags:
JNJ, Medivation, prostatce cancer, Astellas, Dendreon, Sanofi, Zytiga, Xtandi, Provenge
Becton Dickinson buys Alverix for $40M
Yahoo/AP
Tuesday, January 7, 2014 - 12:28pm
tags:
Alverix Technology, devices, Becton Dickinson, M&A
Impax Labs will develop Durect's Eladur shingles pain patch in deal worth up to $63M
Yahoo/AP
Tuesday, January 7, 2014 - 12:27pm
tags:
Durect, shingles, pain patches, Eladur, Impax Labs
FDA Advisory Panel To Review New Heart Failure Drug From Novartis
Forbes
Tuesday, January 7, 2014 - 12:26pm
tags:
FDA, advisory panels, Novartis, serelaxin, heart failure
In search for success, R&D teams are overcrowding small drug franchises
Fierce Pharma
Tuesday, January 7, 2014 - 11:59am
tags:
R&D
Pharmacyclics Shares Rise on Positive Leukemia Trial
Bloomberg
Tuesday, January 7, 2014 - 11:49am
tags:
Pharmacyclics, JNJ, Imbruvica, chronic lymphocytic leukemia
Oppenheimer Sees Five Biotech Stocks to Buy With Potential 50% Upside, or More
24/7 Wall St
Tuesday, January 7, 2014 - 11:47am
tags:
Celldex Therapeutics, Immunomedics, Keryx, Merrimack Pharmaceuticals, Protalix BioTherapeutics
The Twitterverse's Biotech Stock Picks for 2014
TheStreet.com
Tuesday, January 7, 2014 - 11:43am
tags:
biotech, social media, twitter
Will Abbott Perform Better In 2014?
Seeking Alpha
Tuesday, January 7, 2014 - 11:42am
tags:
Abbott Laboratories
Valeant seeks to become top 5 pharmaceutical company -CEO
Yahoo/Reuters
Tuesday, January 7, 2014 - 10:09am
tags:
Valeant Pharmaceuticals, J. Michael Pearson, Pharma CEOs
Progenics Likely To Announce Positive Prostate Cancer Data In January
Seeking Alpha
Tuesday, January 7, 2014 - 9:28am
tags:
prostate cancer, Progenics, Celldex Therapeutics, Seattle Genetics, CytRx, Adcetris
Lilly issues 2014 forecast in line with Wall St estimates
Yahoo/Reuters
Tuesday, January 7, 2014 - 9:27am
tags:
Eli Lilly
Gilead Sales Chief Retires Amidst Key Hep C Drug Launch, Massive Insider Selling
TheStreet.com
Tuesday, January 7, 2014 - 9:26am
tags:
Gilead Sciences, hepatitis C, Sovaldi
Pluristem's Positive Data Could Open Massive Muscle Injury Market
Seeking Alpha
Tuesday, January 7, 2014 - 9:24am
tags:
Pluristem Therapeutics, Stryker, JNJ, Zimmer, hip recall, PLX cell therapy
Obesity Stocks Focus on Approvals As Arena Pharmaceuticals Goes Global
TheStreet.com
Monday, January 6, 2014 - 7:26pm
tags:
drug approvals, Arena Pharmaceuticals, obesity, GSK, Orexigen, Belviq, Eisai
Neurocrine Biosciences shares surge on study
Marketwatch
Monday, January 6, 2014 - 4:58pm
tags:
tardive dyskinesia, Neurocrine Biosciences, NBI-98854
FDA returns for look at risk of Boehringer Ingelheim's Pradaxa
Fierce Pharma
Monday, January 6, 2014 - 4:53pm
tags:
Pradaxa, FDA, Boehringer Ingelheim, bloodthinners
Intercept to Provide Update on Pipeline
Yahoo/Zacks.com
Monday, January 6, 2014 - 4:49pm
tags:
Intercept Pharma, primary biliary cirrhosis
Three biopharma companies poised for product OKs in 2014: analyst
Marketwatch
Monday, January 6, 2014 - 4:34pm
tags:
Cubist, Regeneron, Spectrum
This FDA Letter About Sarepta and Accelerated Approval for Eteplirsen Will Blow Your Mind
TheStreet.com
Monday, January 6, 2014 - 4:25pm
tags:
FDA, Sarepta Therapeutics, Duchenne Muscular Dystrophy, eteplirsen

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

The Bethesda Declaration
In the Pipeline
Taurine and Aging: Is There Anything to It?
In the Pipeline
Cleaning Up the Medical Literature
In the Pipeline
Not One of Your Easy Crystals
In the Pipeline
The Continuing Crisis, Part XV: The Horrendous Trump Budget
In the Pipeline
Taurine Revisited
In the Pipeline
A New Route to Asthma Treatment - Through the Liver, of All Places
In the Pipeline
One Drug's Supply Chain, In Detail
In the Pipeline
A Reaction to Alzheimer's Fraud
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.